Cited by 256Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesRadiomics and Machine Learning in Medical Imaging

The DOI matches its Crossref record; 212 of the 216 references it cites were found in a registry or an index.

Assessing the interactions between radiotherapy and antitumour immunity

Open access

Grassberger, Clemens, Ellsworth, Susannah G., Wilks, Moses Q., Keane, Florence K., Loeffler, Jay S.·2019·Nature Reviews Clinical Oncology

DOI 10.1038/s41571-019-0238-9PMC PMC13492067

Open this paper in CoChat — free account

Abstract

Immunotherapy, specifically the introduction of immune checkpoint inhibitors, has transformed the treatment of cancer, enabling long-term tumour control even in individuals with advanced-stage disease. Unfortunately, only a small subset of patients show a response to currently available immunotherapies. Despite a growing consensus that combining immune checkpoint inhibitors with radiotherapy can increase response rates, this approach might be limited by the development of persistent radiation-induced immunosuppression. The ultimate goal of combining immunotherapy with radiotherapy is to induce a shift from an ineffective, pre-existing immune response to a long-lasting, therapy-induced immune response at all sites of disease. To achieve this goal and enable the adaptation and monitoring of individualized treatment approaches, assessment of the dynamic changes in the immune system at the patient level is essential. In this Review, we summarize the available clinical data, including forthcoming methods to assess the immune response to radiotherapy at the patient level, ranging from serum biomarkers to imaging techniques that enable investigation of immune cell dynamics in patients. Furthermore, we discuss modelling approaches that have been developed to predict the interaction of immunotherapy with radiotherapy, and highlight how they could be combined with biomarkers of antitumour immunity to optimize radiotherapy regimens and maximize their synergy with immunotherapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41571-019-0238-9

Cites

212 of 212 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Rittmeyer, A., Barlési, F., Waterkamp, D., Park, K., Ciardiello, F., von Pawel, J., Gadgeel, S. M., Hida, T., Kowalski, D. M., Cobo, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32517-x · Cited by 4,718
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Kurata, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809697 · Cited by 2,798
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Riaz, N., Havel, J. J., Makarov, V., Desrichard, A., Urba, W. J., Sims, J. S., Hodi, F. S., Martín-Algarra, S., Mandal, R., Sharfman, W. H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.028 · Cited by 2,401
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y. J., Yuan, J. D., Kitano, S., Mu, Z., Rasalan, T. S., Adamow, M. J., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,105
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Vanpouille-Box, C., Alard, A., Aryankalayil, M. J., Sarfraz, Y., Diamond, J. M., Schneider, R. J., Inghirami, G., Coleman, C. N., Formenti, S. C., & Demaria, S. (2017) · Nature Communications · doi:10.1038/ncomms15618 · Cited by 1,834
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1739 · Cited by 1,682
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody
Dewan, M. Z., Galloway, A. E., Kawashima, N., Dewyngaert, J. K., Babb, J. S., Formenti, S. C., & Demaria, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0265 · Cited by 1,678
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
Gupta, D., & Lis, C. G. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-69 · Cited by 1,485
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Demaria, S., Ng, B., Devitt, M. L., Babb, J. S., Kawashima, N., Liebes, L., & Formenti, S. C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.012 · Cited by 1,417
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
McMillan, D. C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.08.003 · Cited by 1,409
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
Thomas, D. A., & Massagué, J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.012 · Cited by 1,355
Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
Dovedi, S. J., Adlard, A. L., Lipowska‐Bhalla, G., McKenna, C., Jones, S., Cheadle, E. J., Stratford, I. J., Poon, E., Morrow, M., Stewart, R. A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1258 · Cited by 1,339
Regional Nodal Irradiation in Early-Stage Breast Cancer
Whelan, T. J., Olivotto, I. A., Parulekar, W. R., Ackerman, I., Chua, B. H., Nabid, A., Vallis, K. A., White, J. R., Rousseau, P., Fortin, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415340 · Cited by 1,316
Using immunotherapy to boost the abscopal effect
Ngwa, W., Irabor, O. C., Schoenfeld, J. D., Hesser, J., Demaria, S., & Formenti, S. C. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2018.6 · Cited by 1,260
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
Sun, R., Limkin, E. J., Vakalopoulou, M., Dercle, L., Champiat, S., Han, S. R., Verlingue, L., Brandao, D., Lancia, A., Ammari, S., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30413-3 · Cited by 1,236
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.
Shaverdian, N., Lisberg, A. E., Bornazyan, K., Veruttipong, D., Goldman, J. W., Formenti, S. C., Garon, E. B., & Lee, P. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30380-7 · Cited by 1,091
Lost in translation: animal models and clinical trials in cancer treatment.
(2014) · Europe PMC (PubMed Central) · Cited by 1,033
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
Demaria, S., Kawashima, N., Yang, A. M., Devitt, M. L., Babb, J. S., Allison, J. P., & Formenti, S. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.728.11.2 · Cited by 1,027
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Formenti, S. C., Rudqvist, N.-P., Golden, E., Cooper, B., Wennerberg, E., Lhuillier, C., Vanpouille-Box, C., Friedman, K., Ferrari de Andrade, L., Wucherpfennig, K. W., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0232-2 · Cited by 928
Pseudoprogression and Immune-Related Response in Solid Tumors
Chiou, V. L., & Burotto, M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6870 · Cited by 905
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Horn, L., Spigel, D. R., Vokes, E. E., Holgado, E., Ready, N., Steins, M. B., Poddubskaya, E. V., Borghaei, H., Felip, E., Paz-Ares, L. G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.3062 · Cited by 875
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
McLaughlin, J. F., Han, G., Schalper, K. A., Carvajal‐Hausdorf, D., Pelekanou, V., Rehman, J., Velcheti, V., Herbst, R. S., LoRusso, P. M., & Rimm, D. L. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3638 · Cited by 845
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
de Vries, I. J. M., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., van Krieken, J. H., Boerman, O. C., Oyen, W. J. G., Bonenkamp, J. J., Boezeman, J. B., Adema, G. J., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1154 · Cited by 821
Identification of prognostic factors in patients with brain metastases: a review of 1292 patients
Lagerwaard, F. J., Levendag, P. C., Nowak, P. J. C. M., Eijkenboom, W. H., Hanssens, P. E. J., & Schmitz, P. I. M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00442-8 · Cited by 721
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shalapour, S., & Karin, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80007 · Cited by 713
The mathematics of cancer: integrating quantitative models
Altrock, P. M., Liu, L. L., & Michor, F. (2015) · Nature reviews. Cancer · doi:10.1038/nrc4029 · Cited by 703
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
Golden, E. B., Chhabra, A. M., Chachoua, A., Adams, S., Donach, M. E., Fenton-Kerimian, M., Friedman, K. P., Ponzo, F., Babb, J. S., Goldberg, J. D., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00054-6 · Cited by 680
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Sharma, P., Wagner, K., Wolchok, J. D., & Allison, J. P. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3153 · Cited by 662
A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth
de Pillis, L. G., Radunskaya, A., & Wiseman, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0564 · Cited by 656
Standardizing methods to address clonality in population studies
Arnaud‐Haond, S., Duarte, C. M., Alberto, F., & Serrão, E. Á. (2007) · Molecular Ecology · doi:10.1111/j.1365-294x.2007.03535.x · Cited by 654
21 years of Biologically Effective Dose
Fowler, J. F. (2010) · British Journal of Radiology · doi:10.1259/bjr/31372149 · Cited by 643
Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth
Benzekry, S., Lamont, C., Beheshti, A., Tracz, A., Ebos, J. M. L., Hlatky, L., & Hahnfeldt, P. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003800 · Cited by 586
Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
Grossman, S. A., Ye, X., Lesser, G. J., Sloan, A. E., Carraway, H. E., Desideri, S., & Piantadosi, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0774 · Cited by 580
Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
Shen, X., & Zhao, B. (2018) · BMJ · doi:10.1136/bmj.k3529 · Cited by 567
Systematic review of case reports on the abscopal effect
Abuodeh, Y. A., Venkat, P. S., & Kim, S. (2015) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2015.10.001 · Cited by 548
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
Willett, C. G., Duda, D. G., di Tomaso, E., Boucher, Y., Ancukiewicz, M., Sahani, D. V., Lahdenranta, J., Chung, D. C., Fischman, A. J., Lauwers, G. Y., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1771 · Cited by 509
Positron Emission Tomography/Computed Tomography for Diagnosis of Prosthetic Valve Endocarditis
Saby, L., Laas, O., Habib, G., Cammilleri, S., Mancini, J., Tessonnier, L., Casalta, J., Gouriet, F., Ribéri, A., Aviérinos, J.-F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.092 · Cited by 503
Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells
Carretero, R., Sektioglu, I. M., Garbi, N., Salgado, O. C., Beckhove, P., & Hämmerling, G. J. (2015) · Nature Immunology · doi:10.1038/ni.3159 · Cited by 501
Charged-particle therapy in cancer: clinical uses and future perspectives
Durante, M., Orecchia, R., & Loeffler, J. S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.30 · Cited by 498
Self-citation
FDG PET of Infection and Inflammation
Love, C., Tomas, M. B., Tronco, G. G., & Palestro, C. J. (2005) · Radiographics · doi:10.1148/rg.255045122 · Cited by 484
Acquired resistance to immunotherapy and future challenges
Restifo, N. P., Smyth, M. J., & Snyder, A. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.2 · Cited by 470
Detection of Atherosclerotic Inflammation by 68 Ga-DOTATATE PET Compared to [ 18 F]FDG PET Imaging
Tarkin, J. M., Joshi, F. R., Evans, N. R., Chowdhury, M. M., Figg, N. L., Shah, A. V., Starks, L. T., Garrido, A. M., Manavaki, R., Yu, E., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.060 · Cited by 457
Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models
Eftimie, R., Bramson, J. L., & Earn, D. J. D. (2010) · Bulletin of Mathematical Biology · doi:10.1007/s11538-010-9526-3 · Cited by 436
18Fluorodeoxyglucose Positron Emission Tomography Imaging of Atherosclerotic Plaque Inflammation Is Highly Reproducible
Rudd, J. H. F., Myers, K. S., Bansilal, S., Macháč, J., Rafique, A., Farkouh, M. E., Fuster, V., & Fayad, Z. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.024 · Cited by 429
The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
Stamell, E. F., Wolchok, J. D., Gnjatic, S., Lee, N. Y., & Brownell, I. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.03.017 · Cited by 387
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Lipson, E. J., Vincent, J. G., Loyo, M., Kagohara, L. T., Luber, B. S., Wang, H., Xu, H., Nayar, S. K., Wang, T. S., Sidransky, D., et al. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0034 · Cited by 384
Overlap and Effective Size of the Human CD8 + T Cell Receptor Repertoire
Robins, H. S., Srivastava, S. K., Campregher, P. V., Turtle, C. J., Andriesen, J. G., Riddell, S. R., Carlson, C. S., & Warren, E. H. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001442 · Cited by 383
Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients
Cha, E., Klinger, M., Hou, Y., Cummings, C., Ribas, A., Faham, M., & Fong, L. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008211 · Cited by 383
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
Tang, J., Yu, J. X., Hubbard-Lucey, V. M., Neftelinov, S. T., Hodge, J. P., & Lin, Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.210 · Cited by 382
Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes
Tang, C. Z., Liao, Z. X., Gomez, D. R., Levy, L. B., Zhuang, Y., Gebremichael, R. A., Hong, D. S., Komaki, R. U., & Welsh, J. W. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.04.025 · Cited by 375
Forum: On Resisting Resistance
Brown, M. F. (1996) · American Anthropologist · doi:10.1525/aa.1996.98.4.02a00030 · Cited by 367
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy
Marciscano, A. E. E., Ghasemzadeh, A., Nirschl, T. R., Theodros, D., Kochel, C. M., Francica, B. J., Muroyama, Y., Anders, R. A., Sharabi, A. B., Velarde, E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3427 · Cited by 364
Radiation as an immunological adjuvant: current evidence on dose and fractionation
Demaria, S., & Formenti, S. C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00153 · Cited by 346
Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction
Gerassy-Vainberg, S., Blatt, A., Danin‐Poleg, Y., Gershovich, K., Sabo, E., Nevelsky, A., Daniel, S., Dahan, A., Ziv, O., Dheer, R., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-313789 · Cited by 331
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
Young, K. H., Baird, J. R., Savage, T., Cottam, B., Friedman, D. J., Bambina, S., Messenheimer, D. J., Fox, B. A., Newell, P., Bahjat, K. S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157164 · Cited by 330
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Tang, C. Z., Welsh, J. W., de Groot, P. M., Massarelli, E., Chang, J. Y., Hess, K. R., Basu, S., Curran, M. A., Cabanillas, M. E., Subbiah, V., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1432 · Cited by 327
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
Derks, S., Liao, X., Chiaravalli, A. M., Xu, X., Camargo, M. C., Solcia, E., Sessa, F., Fleitas, T., Freeman, G. J., Rodig, S. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9076 · Cited by 310
MRI of Tumor-Associated Macrophages with Clinically Applicable Iron Oxide Nanoparticles
Daldrup-Link, H. E., Golovko, D. M., Ruffell, B., DeNardo, D. G., Castaneda, R., Ansari, C., Rao, J., Tikhomirov, G. A., Wendland, M. F., Corot, C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3420 · Cited by 307
Tumor Irradiation Increases the Recruitment of Circulating Mesenchymal Stem Cells into the Tumor Microenvironment
Klopp, A. H., Spaeth, E. L., Dembinski, J. L., Woodward, W. A., Munshi, A., Meyn, R. E., Cox, J. D., Andreeff, M., & Marini, F. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1406 · Cited by 304
The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis
Dolan, R. D., Lim, J. E. K., McSorley, S. T., Horgan, P. G., & McMillan, D. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-16955-5 · Cited by 302
Safety of combining radiotherapy with immune-checkpoint inhibition
Hwang, W. L., Pike, L., Royce, T. J., Mahal, B. A. V., & Loeffler, J. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0046-7 · Cited by 299
Self-citation
The Model Muddle: In Search of Tumor Growth Laws
Gerlee, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4355 · Cited by 288
Usefulness of Fluorine-18 Positron Emission Tomography/Computed Tomography for Identification of Cardiovascular Implantable Electronic Device Infections
SARRAZIN, J., Philippon, F., Tessier, M., Guimond, J. V., Molin, F., Champagne, J., Nault, I., Blier, L. E., Nadeau, M., Charbonneau, L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.059 · Cited by 284
Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.
FUKS, Z. Y., Strober, S., Bobrove, A. M., Sasazuki, T., McMichael, A. J., & Kaplan, H. S. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108532 · Cited by 272
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
Neuwelt, E. A., Hamilton, B. E., Varallyay, C. G., Rooney, W. R., Edelman, R. D., Jacobs, P. M., & Watnick, S. G. (2009) · Kidney International · doi:10.1038/ki.2008.496 · Cited by 267
Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation
Wykrzykowska, J. J., Lehman, S., Williams, G., Parker, J. A., Palmer, M. R., Varkey, S. C., Kolodny, G. M., & Laham, R. J. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.055616 · Cited by 263
Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy
Davuluri, R., Jiang, W., Fang, P., Xu, C., Komaki, R. R., Gomez, D. R., Welsh, J. W., Cox, J. D., Crane, C. H., Hsu, C. C.-C., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.05.037 · Cited by 260
Evolution of acquired resistance to anti-cancer therapy
Foo, J., & Michor, F. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.02.025 · Cited by 257
A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
Hiniker, S. M., Chen, D. S., Reddy, S. A., Chang, D. T., Jones, J. C., Mollick, J. A., Swetter, S. M., & Knox, S. J. (2012) · Translational Oncology · doi:10.1593/tlo.12280 · Cited by 247
TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo
Bouquet, F., Pal, A., Pilones, K. A., Demaria, S., Hann, B. C., Akhurst, R. J., Babb, J. S., Lonning, S. M., DeWyngaert, J. K., Formenti, S. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0544 · Cited by 247
Guidelines for the labelling of leucocytes with 99mTc-HMPAO
de Vries, E. F. J., Roca, M., Jamar, F., Israel, O., & Signore, A. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1394-4 · Cited by 245
A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab
Chandra, R. A., Wilhite, T. J., Balboni, T. A., Alexander, B. M., Spektor, A., Ott, P. A., Ng, A. K., Hodi, F. S., & Schoenfeld, J. D. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1046028 · Cited by 236
Treatment-related Lymphopenia in Patients With Stage III Non-Small-Cell Lung Cancer
Campian, J. L., Ye, X., Brock, M. V., & Grossman, S. A. (2013) · Cancer Investigation · doi:10.3109/07357907.2013.767342 · Cited by 233
Added Value of 99m Tc-HMPAO–Labeled Leukocyte SPECT/CT in the Characterization and Management of Patients with Infectious Endocarditis
Erba, P. A., Conti, U., Lazzeri, E., Sollini, M., Doria, R., Tommasi, S. M. D., Bandera, F., Tascini, C., Menichetti, F., Dierckx, R., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.099424 · Cited by 225
Correction: Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
Cayrol, F., Praditsuktavorn, P., Fernando, T. M., Kwiatkowski, N. P., Marullo, R., Calvo-Vidal, M. N., Phillip, J. M., Pera, B., Yang, S. N., Takpradit, K., et al. (2017) · Nature Communications · doi:10.1038/ncomms14747 · Cited by 220
Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer.
Chakravarty, P. K., Alfieri, A. A., Thomas, E. K., Beri, V., Tanaka, K. E., Vikram, B., & Guha, C. (1999) · PubMed · Cited by 218
Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates
Hannestad, J. O., Gallezot, J., Schafbauer, T., Lim, K., Kloczynski, T., Morris, E. D., Carson, R. E., Ding, Y., & Cosgrove, K. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.055 · Cited by 218
Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells
Rudqvist, N.-P., Pilones, K. A., Lhuillier, C., Wennerberg, E., Sidhom, J.-W., Emerson, R., Robins, H. S., Schneck, J. P., Formenti, S. C., & Demaria, S. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0134 · Cited by 217
The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma
Wild, A. T., Ye, X., Ellsworth, S. G., Smith, J. A., Narang, A. K., Garg, T., Campian, J. L., Laheru, D. A., Zheng, L., Wolfgang, C. L., et al. (2013) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3182940ff9 · Cited by 211
Self-citation
Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers
Afanasiev, O. K., Yelistratova, L., Miller, N. J., Nagase, K., Paulson, K. G., Iyer, J. G., Ibrani, D., Koelle, D. M., & Nghiem, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0035 · Cited by 209
PET and SPECT in Osteomyelitis and Prosthetic Bone and Joint Infections: A Systematic Review
van der Bruggen, W., Bleeker‐Rovers, C. P., Boerman, O. C., Gotthardt, M., & Oyen, W. J. G. (2009) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2009.08.005 · Cited by 209
The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens
Simon, R. M., & Norton, L. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0560 · Cited by 208
T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma
Stromnes, I. M., Hulbert, A., Pierce, R. H., Greenberg, P. D., & Hingorani, S. R. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0322 · Cited by 206
Guidelines for the labelling of leucocytes with 111In-oxine
Roca, M., de Vries, E. F. J., Jamar, F., Israel, O., & Signore, A. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1393-5 · Cited by 205
Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences
Brix, N., Tiefenthaller, A., Anders, H., Belka, C., & Lauber, K. (2017) · Immunological Reviews · doi:10.1111/imr.12573 · Cited by 204
CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)
Balermpas, P., Rödel, F., Rödel, C. M., Krause, M., Linge, A., Lohaus, F., Baumann, M. A., Tinhofer, I., Budach, V., Gkika, E., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29683 · Cited by 200
Mathematical and computational models of immune-receptor signalling
Goldstein, B., Faeder, J. R., & Hlavacek, W. S. (2004) · Nature reviews. Immunology · doi:10.1038/nri1374 · Cited by 199
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging
Thu, M. S., Bryant, L. H., Coppola, T., Jordan, E. K., Budde, M. D., Lewis, B. K., Chaudhry, A., Ren, J., Varma, N. R. S., Arbab, A. S., et al. (2012) · Nature Medicine · doi:10.1038/nm.2666 · Cited by 195
Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
Ellsworth, S. G. (2018) · Advances in Radiation Oncology · doi:10.1016/j.adro.2018.08.014 · Cited by 195
Self-citation
The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors
Pike, L., Bang, A., Mahal, B. A. V., Taylor, A., Krishnan, M. S., Spektor, A., Cagney, D. N., Aizer, A. A., Alexander, B. M., Rahma, O. E., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.09.010 · Cited by 194
Angiogenesis as a marker of preneoplastic lesions of the human breast
Brem, S. S., Jensen, H. M., & Gullino, P. M. (1978) · Cancer · doi:10.1002/1097-0142(197801)41:1 · Cited by 191
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation
Neuwelt, A., Sidhu, N., Hu, C.-A. A., Mlady, G., Eberhardt, S. C., & Sillerud, L. O. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.12733 · Cited by 189
What does physics have to do with cancer?
Michor, F., Liphardt, J., Mauro Ferrari, B., & Widom, J. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3092 · Cited by 184
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
Vanpouille‐Box, C., Pilones, K. A., Wennerberg, E., Formenti, S. C., & Demaria, S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.105 · Cited by 180
Lymphocyte numbers and subsets in the human blood
Blum, K. S., & Pabst, R. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.10.009 · Cited by 176
Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy
Serre, R., Benzekry, S., Padovani, L., Meille, C., André, N., Ciccolini, J., Barlési, F., Muracciole, X., & Barbolosi, D. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3567 · Cited by 169
Engineered antibody fragments for immuno-PET imaging of endogenous CD8 + T cells in vivo
Tavaré, R., McCracken, M. N., Zettlitz, K. A., Knowles, S. M., Salazar, F. B., Olafsen, T., Witte, O. N., & Wu, A. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316922111 · Cited by 167
Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein–Barr virus-associated gastric cancer: the prognostic implications
Saito, R., Abé, H., Kunita, A., Yamashita, H., Seto, Y., & Fukayama, M. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.202 · Cited by 158
The Association Between Treatment-Related Lymphopenia and Survival in Newly Diagnosed Patients with Resected Adenocarcinoma of the Pancreas
Balmanoukian, A. S., Ye, X., Herman, J. M., Laheru, D. A., & Grossman, S. A. (2012) · Cancer Investigation · doi:10.3109/07357907.2012.700987 · Cited by 154
Radiation-Induced Lymphocyte-Immune Deficiency
Meyer, K. K. (1970) · Archives of Surgery · doi:10.1001/archsurg.1970.01340260018003 · Cited by 146
Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme
Fadul, C. E., Fisher, J. L., Gui, J., Hampton, T. H., Côté, A. L., & Ernstoff, M. S. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq204 · Cited by 146
Targeting the TGF-β1 Pathway to Prevent Normal Tissue Injury After Cancer Therapy
Anscher, M. S. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-s101 · Cited by 142
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer
Lim, S. H., Hong, M. E., Ahn, S. W., Choi, Y., Kim, K.-M., Oh, D., Ahn, Y. C., Jung, S., Ahn, M., Park, K., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.09.019 · Cited by 142
Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100 Positron Emission Tomography
Nimmagadda, S., Pullambhatla, M., Stone, K. L., Green, G. M., Bhujwalla, Z. M., & Pomper, M. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4396 · Cited by 137
Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer
Guthrie, G. J. K., Roxburgh, C. S. D., Farhan‐Alanie, O. M., Horgan, P. G., & McMillan, D. C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.330 · Cited by 136
68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors
Li, X., Samnick, S., Lapa, C., Israel, I., Buck, A. K., Kreissl, M. C., & Bauer, W. R. (2012) · EJNMMI Research · doi:10.1186/2191-219x-2-52 · Cited by 124
Mature B cells accelerate wound healing after acute and chronic diabetic skin lesions
Sîrbulescu, R. F., Boehm, C. K., Soon, E., Wilks, M. Q., Ilieş, I., Yuan, H., Maxner, B., Chronos, N. A. F., Kaittanis, C., Normandin, M. D., et al. (2017) · Wound Repair and Regeneration · doi:10.1111/wrr.12584 · Cited by 123
Self-citation
Noninvasive PET Imaging of T cells
Wei, W., Jiang, D., Ehlerding, E. B., Luo, Q., & Cai, W. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.03.009 · Cited by 121
Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma
Mendez, J. S., Govindan, A., Leong, J., Gao, F., Huang, J., & Campian, J. L. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-2037-1 · Cited by 119
Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions
Poleszczuk, J., Luddy, K. A., Prokopiou, S., Robertson‐Tessi, M., Moros, E. G., Fishman, M., Djeu, J. Y., Finkelstein, S. E., & Enderling, H. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1423 · Cited by 119
A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma
Crocenzi, T. S., Cottam, B., Newell, P., Wolf, R., Hansen, P., Hammill, C. W., Solhjem, M. C., To, Y.-Y., Greathouse, A., Tormoen, G. W., et al. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0149-6 · Cited by 114
Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
Chadha, A. S., Liu, G., Chen, H.-C., Das, P., Minsky, B. D., Mahmood, U. X., Delclos, M. E., Suh, Y., Sawakuchi, G. O., Beddar, S. A., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.10.046 · Cited by 111
Predator-prey equations simulating an immune response
Bell, G. I. (1973) · Mathematical Biosciences · doi:10.1016/0025-5564(73)90036-9 · Cited by 106
Human papilloma virus load and PD-1/PD-L1, CD8 + and FOXP3 in anal cancer patients treated with chemoradiotherapy: Rationale for immunotherapy
Balermpas, P., Martin, D., Wieland, U., Rave‐Fränk, M., Strebhardt, K., Rödel, C. M., Fokas, E., & Rödel, F. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1288331 · Cited by 106
Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque
Camici, P. G., Rimoldi, O. E., Gaemperli, O., & Libby, P. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs067 · Cited by 105
Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma
Rudra, S. F., Hui, C., Rao, Y. J., Samson, P. P., Lin, A. J., Chang, X., Tsien, C. I., Fergus, S., Mullen, D. F., Yang, D., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.01.069 · Cited by 105
Radiation and PD-(L)1 treatment combinations: immune response and dose optimization via a predictive systems model
Kosinsky, Y., Dovedi, S. J., Peskov, K. V., Voronova, V., Chu, L., Tomkinson, H. K., Al-Huniti, N. H., Stanski, D. R., & Helmlinger, G. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0327-9 · Cited by 105
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
Chen, H.-M., Ma, G., Gildener‐Leapman, N., Eisenstein, S. G., Coakley, B. A., Ozao, J. J., Mandeli, J., Divino, C. M., Schwartz, M., Sung, M. W., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2742 · Cited by 104
In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis
Kirschbaum, K., Sonner, J. K., Zeller, M. W. G., Deumelandt, K., Bode, J., Sharma, R. K., Krüwel, T., Fischer, M. D., Hoffmann, A., da Silva, M. C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609397113 · Cited by 103
Chemoradiotherapy-Induced Upregulation of PD-1 Antagonizes Immunity to HPV-Related Oropharyngeal Cancer
Parikh, F. S., Duluc, D., Imai, N., Clark, A., Misiukiewicz, K., Bonomi, M., Gupta, V., Patsias, A., Parides, M. K., Demicco, E. G., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1913 · Cited by 102
Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer
Cho, O., Oh, Y., Chun, M., Noh, O. K., & Lee, H. W. (2015) · Tumor Biology · doi:10.1007/s13277-015-3888-y · Cited by 90
Advances in SPECT and PET Hardware
Slomka, P. J., Pan, T., Berman, D. S., & Germano, G. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.02.002 · Cited by 88
Behavior of tumors under nonstationary therapy
Sotolongo-Costa, O., Molina, L. M., Pérez, D. R., Antoranz, J. C., & Reyes, M. C. (2003) · Physica D Nonlinear Phenomena · doi:10.1016/s0167-2789(03)00005-8 · Cited by 88
Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8+ Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis
Lim, Y. J., Koh, J., Kim, S., Jeon, S. R., Chie, E. K., Kim, K., Kang, G. H., Han, S., Kim, T., Jeong, S., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.07.004 · Cited by 87
Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes
Fernandes, A., Shen, J., Finlay, J. C., Mitra, N., Evans, T. L., Stevenson, J. P., Langer, C. J., Lin, L. L., Hahn, S. M., GLATSTEIN, E. J., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.02.007 · Cited by 86
Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients
Fujimoto, D., Uehara, K., Sato, Y., Sakanoue, I., Ito, M., Teraoka, S., Nagata, K., Nakagawa, A., Kosaka, Y., Otsuka, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11949-9 · Cited by 86
The Immunoimaging Toolbox
Mayer, A. T., & Gambhir, S. S. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.185967 · Cited by 85
Sustained CD4+T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide
Ellsworth, S. G., Balmanoukian, A. S., Kos, F. J., Nirschl, C. J., Nirschl, T. R., Grossman, S. A., Luznik, L., & Drake, C. G. (2014) · OncoImmunology · doi:10.4161/onci.27357 · Cited by 83
Self-citation
The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients
Liu, L., Chen, Q.-Y., Tang, L., Guo, S.-S., Guo, L., Mo, H., Chen, M., Zhao, C., Guo, X., Qian, C.-N., et al. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2016.595 · Cited by 80
11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis
Datta, G., Colasanti, A., Kalk, N., Owen, D. R., Scott, G. P. T., Rabiner, E., Gunn, R., Lingford-Hughes, A., Malik, O., Ciccarelli, O., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.187161 · Cited by 78
Kill and Spread the Word: Stimulation of Antitumor Immune Responses in the Context of Radiotherapy
Gaipl, U. S., Multhoff, G., Scheithauer, H., Lauber, K., Hehlgans, S., Frey, B., & Rödel, F. (2014) · Immunotherapy · doi:10.2217/imt.14.38 · Cited by 78
Gadolinium(III)-Gold Nanorods for MRI and Photoacoustic Imaging Dual-Modality Detection of Macrophages in Atherosclerotic Inflammation
Qin, H., Zhou, T., Yang, S., Chen, Q., & Xing, D. (2013) · Nanomedicine · doi:10.2217/nnm.12.168 · Cited by 75
Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell Lymphomas
Olafsen, T., Betting, D. J., Kenanova, V. E., Salazar, F. B., Clarke, P. J., SAID, J. W., Raubitschek, A. A., Timmerman, J. M., & Wu, A. M. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060426 · Cited by 74
Prognostic Value of Severe Lymphopenia During Pelvic Concurrent Chemoradiotherapy in Cervical Cancer.
Cho, O., Chun, M., Chang, S., Yt, O., & Ok, N. (2016) · PubMed · Cited by 74
The clinical and prognostic significance of CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy
Wang, D., An, G., Xie, S., Yao, Y., & Feng, G. (2016) · Tumor Biology · doi:10.1007/s13277-016-4916-2 · Cited by 73
Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach
Benzekry, S., Tracz, A., Mastri, M., Corbelli, R., Barbolosi, D., & Ebos, J. M. L. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1389 · Cited by 71
Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent
Walczak, P., Ruı́z-Cabello, J., Kedziorek, D., Gilad, A. A., Lin, S., Barnett, B. P., Lu, Q., Levitsky, H. I., & Bulte, J. W. M. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.01.003 · Cited by 71
T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire
Beausang, J. F., Wheeler, A. J., Chan, N. H., Hanft, V. R., Dirbas, F. M., Jeffrey, S. S., & Quake, S. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713863114 · Cited by 71
Nuclear medicine and infection detection: the relative effectiveness of imaging with 111In-oxine-, 99mTc-HMPAO-, and 99mTc-stannous fluoride colloid-labeled leukocytes and with 67Ga-citrate.
Hughes, D. K. (2003) · PubMed · Cited by 69
Increased diversity with reduced “diversity evenness” of tumor infiltrating T-cells for the successful cancer immunotherapy
Hosoi, A., Takeda, K., Nagaoka, K., Iino, T., Matsushita, H., Ueha, S., Aoki, S., Matsushima, K., Kubo, M., Morikawa, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19548-y · Cited by 69
Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer
Le, Q., Fisher, R., Oliner, K. S., Young, R. J., Cao, H., Kong, C. S., Graves, E. E., Hicks, R. J., McArthur, G. A., Peters, L., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2094 · Cited by 66
Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment
Wei, Y., Zhao, M., Yang, F., Mao, Y., Xie, H., & Zhou, Q. (2016) · Scientific Reports · doi:10.1038/srep29110 · Cited by 65
Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide
Campian, J. L., Piotrowski, A., Ye, X., Hakim, F. T., Rose, J. J., Yan, X.-Y., Lu, Y., Gress, R. E., & Grossman, S. A. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2580-z · Cited by 62
The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
Poleszczuk, J., & Enderling, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113377 · Cited by 62
High ratio of programmed cell death protein 1 (PD-1)+/CD8+ tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy
Lim, Y. J., Koh, J., Kim, K., Chie, E. K., Kim, B., Lee, K. B., Jang, J., Kim, S., Oh, D., Bang, Y., et al. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.07.003 · Cited by 61
PET/CT Imaging of Inflammatory Bowel Disease
Perlman, S. B., Hall, B. S., & Reichelderfer, M. (2013) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2013.06.006 · Cited by 60
Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice
Akutsu, Y., Matsubara, H., Urashima, T., Komatsu, A., Sakata, H., Nishimori, T., Yoneyama, Y., Hoshino, I., Murakami, K., Usui, A., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.3.509 · Cited by 56
FDG–PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis
Davies, J. R., Izquierdo‐Garcia, D., Rudd, J. H. F., Figg, N. L., Richards, H. K., Bird, J., Aigbirhio, F. I., Davenport, A. P., Weissberg, P. L., Fryer, T. D., et al. (2009) · International journal of cardiac imaging · doi:10.1007/s10554-009-9506-6 · Cited by 53
Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract
Schiavone, M. B., Broach, V. A., Shoushtari, A. N., Carvajal, R. D., Alektiar, K. M., Kollmeier, M. A., Abu‐Rustum, N. R., & Leitão, M. M. (2016) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2016.04.001 · Cited by 53
Involved field radiotherapy (IFRT) versus elective nodal irradiation (ENI) for locally advanced non-small cell lung cancer: a meta-analysis of incidence of elective nodal failure (ENF)
Li, R., Yu, L., Lin, S., Wang, L., Dong, X., Yu, L., Li, W., & Li, B. (2016) · Radiation Oncology · doi:10.1186/s13014-016-0698-3 · Cited by 52
Heat-induced radiolabeling and fluorescence labeling of Feraheme nanoparticles for PET/SPECT imaging and flow cytometry
Yuan, H., Wilks, M. Q., Normandin, M. D., Fakhri, G. E., Kaittanis, C., & Josephson, L. (2018) · Nature Protocols · doi:10.1038/nprot.2017.133 · Cited by 52
Self-citation
ImmunoPET of Malignant and Normal B Cells with 89Zr- and 124I-Labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization In Vivo
Zettlitz, K. A., Tavaré, R., Knowles, S. M., Steward, K. K., Timmerman, J. M., & Wu, A. M. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0855 · Cited by 51
Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion
Saby, L., Habib, G., Laas, O., Cammilleri, S., Casalta, J., Gouriet, F., Ribéri, A., Aviérinos, J.-F., Raoult, D., & Thuny, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht311.5950 · Cited by 50
Mathematical Modeling in Immunotherapy of Cancer: Personalizing Clinical Trials
Agur, Z., & Vuk‐Pavlović, S. (2012) · Molecular Therapy · doi:10.1038/mt.2011.272 · Cited by 48
Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy
Walker, R., Poleszczuk, J., Pilon‐Thomas, S., Kim, S., Anderson, A. R. A., Czerniecki, B. J., Harrison, L. B., Moros, E. G., & Enderling, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-27718-1 · Cited by 45
From concept to clinic: Mathematically informed immunotherapy
Walker, R., & Enderling, H. (2015) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2015.10.004 · Cited by 45
Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT.
Mojtahedi, A., Alavi, A. A., Thamake, S. I., Amerinia, R., Ranganathan, D., Tworowska, I., & Delpassand, E. S. (2015) · Europe PMC (PubMed Central) · Cited by 43
Imaging of the Vulnerable Carotid Plaque: Biological Targeting of Inflammation in Atherosclerosis using Iron Oxide Particles and MRI
Chan, J. M. S., Monaco, C. G., Wylezinska, M., Tremoleda, J. L., & Gibbs, R. G. J. (2014) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2014.01.017 · Cited by 43
Resisting Resistance
Božić, I., & Nowak, M. A. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-042716-094839 · Cited by 42
Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT
Walther, M., Gebhardt, P., Grosse‐Gehling, P., Würbach, L., Irmler, I. M., Preusche, S., Khalid, M., Opfermann, T., Kamradt, T., Steinbach, J., et al. (2011) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2011.02.040 · Cited by 39
Programmed Death Ligand 1 Expression in Paired Non–Small Cell Lung Cancer Tumor Samples
Cho, J. H., Sorensen, S. F., Choi, Y., Feng, Y., Kim, T., Choi, H., Georgsen, J. B., Dolled-Filhart, M. P., Emancipator, K., Meldgaard, P., et al. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.04.008 · Cited by 39
Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV-Infected Individuals
Zanni, M. V., Toribio, M. P., Wilks, M. Q., Lu, M. T., Burdo, T. H., Walker, J., Autissier, P., Foldyna, B., Stone, L. A., Martin, A., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix095 · Cited by 39
Self-citation
MPI cell tracking: what can we learn from MRI?
Bulte, J. W. M., Walczak, P., Gleich, B., Weizenecker, J., Markov, D. E., Aerts, H. C. J., Boeve, H., Borgert, J., & Kuhn, M. H. (2011) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.879844 · Cited by 37
Inflammatory Bowel Disease: MR- and SPECT/CT-based Macrophage Imaging for Monitoring and Evaluating Disease Activity in Experimental Mouse Model—Pilot Study
Wu, Y., Briley-Saebo, K. C., Xie, J., Ruihua, Z., Wang, Z., He, C., Tang, C. Y., & Tao, X. (2014) · Radiology · doi:10.1148/radiol.13122254 · Cited by 37
Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes
Yang, Z., Zhao, N., Meng, J., Shi, Z., Li, B.-X., Wu, X., Li, P., Zhang, Q., Wei, X., & Fu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8389 · Cited by 36
Influence of PD-L1 expression in immune cells on the response to radiation therapy in patients with oropharyngeal squamous cell carcinoma
Fukushima, Y., Someya, M., Nakata, K., Hori, M., Kitagawa, M., Hasegawa, T., Tsuchiya, T., Gocho, T., Ikeda, H., Hirohashi, Y., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.08.023 · Cited by 36
Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer
Grassberger, C., Hong, T. S., Hato, T., Yeap, B. Y., Wo, J. Y.-L., Tracy, M., Bortfeld, T. R., Wolfgang, J. A., Eyler, C. E., Goyal, L., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.04.026 · Cited by 35
Self-citation
General Aspects of Modeling Tumor Growth and Immune Response
Adam, J. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-0-8176-8119-7_2 · Cited by 34
Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer – Evidence from a phase II trial
Colaco, R. J., Sheikh, H. Y., Lorigan, P. C., Blackhall, F. H., Hulse, P. A., Califano, R., Ashcroft, L., Taylor, P., Thatcher, N. J., & Finn, C. F. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.09.015 · Cited by 32
Heat‐Induced Radiolabeling of Nanoparticles for Monocyte Tracking by PET
Normandin, M. D., Yuan, H., Wilks, M. Q., Chen, H. H., Kinsella, J. M., Cho, H., Guehl, N. J., Absi‐Halabi, N., Hosseini, S. M., Fakhri, G. E., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201505525 · Cited by 31
Self-citation
Models of Models: A Translational Route for Cancer Treatment and Drug Development
Ogilvie, L. A., Kovachev, A., Wierling, C., Lange, B. M. H., & Lehrach, H. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00219 · Cited by 28
Involved field irradiation for the treatment of esophageal cancer: Is it better than elective nodal irradiation?
Jiang, L., Zhao, X., Meng, X., & Yu, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.045 · Cited by 27
Bone Marrow Transplantation Alters the Tremor Phenotype in the Murine Model of Globoid-Cell Leukodystrophy
Reddy, A. S., Wozniak, D. F., Farber, N. B., Dearborn, J. T., Fowler, S. C., & Sands, M. S. (2012) · Journal of Clinical Medicine · doi:10.3390/jcm1010001 · Cited by 26
Comparison between Tc-HMPAO labelled white cells and Tc LeukoScan in the investigation of inflammatory bowel disease
Kerry, J., Marshall, C., Griffiths, P. A., James, M. W., & SCOTT, B. B. (2005) · Nuclear Medicine Communications · doi:10.1097/00006231-200503000-00009 · Cited by 25
Immunologically effective dose: a practical model for immuno-radiotherapy
Serre, R., Barlési, F., Muracciole, X., & Barbolosi, D. (2018) · Oncotarget · doi:10.18632/oncotarget.25746 · Cited by 25
Imaging of carrageenan-induced local inflammation and adjuvant-induced systemic arthritis with [11C]PBR28 PET
Shao, X., Wang, X., English, S. J., Desmond, T. J., Sherman, P. S., Quesada, C., & Piert, M. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.06.008 · Cited by 24
Immunotherapy in Non-Small-Cell Lung Cancer: Potential Predictors of Response and New Strategies to Assess Activity
Rossi, S., Castello, A., Toschi, L., & Lopci, E. (2018) · Immunotherapy · doi:10.2217/imt-2017-0187 · Cited by 23
New SPECT and PET Radiopharmaceuticals for Imaging Inflammatory Diseases: A Meta-analysis of the Last 10 Years.
Pacilio, M., Lauri, C., Prosperi, D., Petitti, A., & Signore, A. (2018) · Seminars in nuclear medicine · doi:10.1053/j.semnuclmed.2017.12.004 · Cited by 22
Methodologies in the modeling of combined chemo-radiation treatments
Grassberger, C., & Paganetti, H. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/21/r344 · Cited by 22
Self-citation
The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy
Önal, C., Yıldırım, B. A., Güler, O. C., & Mertsoylu, H. (2018) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001345 · Cited by 22
Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus–Positive Patients With Anal Cancer
Bryant, A. K., Mudgway, R., Huynh‐Le, M., Simpson, D. R., Mell, L. K., Gupta, S. N., Sharabi, A. B., & Murphy, J. D. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.09.034 · Cited by 21
Mathematical modelling of the synergistic combination of radiotherapy and indoleamine-2,3-dioxygenase (IDO) inhibitory immunotherapy against glioblastoma
Chakwizira, A., Ahlstedt, J., Redebrandt, H. N., & Ceberg, C. P. (2018) · British Journal of Radiology · doi:10.1259/bjr.20170857 · Cited by 21
Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: a case report and immunological analysis
Teulings, H. E., Tjin, E. P. M., Willemsen, K. J., Krebbers, G., van Noesel, C. J. M., Kemp, E. H., Nieuweboer‐Krobotová, L., van der Veen, J. P. W., & Luiten, R. M. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12136 · Cited by 20
Varied Effects of Thoracic Irradiation on Peripheral Lymphocyte Subsets in Lung Cancer Patients.
NAKAYAMA, Y., Makino, S., Fukuda, Y., Min, K., Ikemoto, T., Shimizu, A., & Ohsawa, N. (1995) · Internal Medicine · doi:10.2169/internalmedicine.34.959 · Cited by 20
Heat-induced-radiolabeling and click chemistry: A powerful combination for generating multifunctional nanomaterials
Yuan, H., Wilks, M. Q., Fakhri, G. E., Normandin, M. D., Kaittanis, C., & Josephson, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172722 · Cited by 19
Self-citation
TGF-β inhibits IL-7-induced proliferation in memory but not naive human CD4+ T cells
Nguyen, T. P., & Sieg, S. F. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1216-520rr · Cited by 19
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
Evans, R. L., Pottala, J. V., Nagata, S., & Egland, K. A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4022-5 · Cited by 19
Transcriptome analysis of low-dose ionizing radiation-impacted genes in CD4 + T-cells undergoing activation and regulation of their expression of select cytokines
Cho, S.-J., Kang, H., Hong, E., Kim, J.-Y., & Nam, S. Y. (2018) · Journal of Immunotoxicology · doi:10.1080/1547691x.2018.1521484 · Cited by 19
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach
Cope, F. O., Abbruzzese, B. C., Sanders, J., Metz, W., Sturms, K., Ralph, D. A., Blue, M., Zhang, J., Bracci, P. M., Bshara, W., et al. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.11.007 · Cited by 17
Pitfalls and Limitations of SPECT, PET, and Therapeutic Radiopharmaceuticals
Ballinger, J. R. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.02.007 · Cited by 16
Essential Elements to Consider for MRI Cell Tracking Studies with Iron Oxide-based Labeling Agents.
Wang, P. C., & Shan, L. (2012) · PubMed · Cited by 15
Diagnose septischer Hüftprothesenlockerung via LeukoScan
Kaisidis, A., Megas, P., Apostolopoulos, D., Spiridonidis, T., Koumoundourou, D., Zouboulis, P., Lambiris, E., & Vassilakos, P. (2005) · Der Orthopäde · doi:10.1007/s00132-005-0777-x · Cited by 14

Sorted by citations

Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 811
Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer
Sia, J., Szmyd, R., Hau, E., & Gee, H. E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00041 · Cited by 378
Towards clinical translation of FLASH radiotherapy
Vozenin, M., Bourhis, J., & Durante, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00697-z · Cited by 370
Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy
Li, J., Luo, Y., & Pu, K. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202008386 · Cited by 223
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Mirzaei, S., Gholami, M. H., Zabolian, A., Saleki, H., Farahani, M. V., Hamzehlou, S., Far, F. B., Sharifzadeh, S. O., Samarghandian, S., Khan, H. Z., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105759 · Cited by 191

See all 256

Authors: Grassberger, C., Ellsworth, S. G., Wilks, M. Q., Keane, F. K., & Loeffler, J. S.
Affiliations: Harvard University (US)
Indiana University School of Medicine (US)
Gordon Center for Medical Imaging (US)
Corresponding author: Grassberger, Clemens
ORCID: Grassberger, Clemens
Ellsworth, Susannah G.
Keane, Florence K.
Venue: Nature Reviews Clinical Oncology
Publisher: Springer Science and Business Media LLC
Published: 2019-06-26
Volume: 16
Issue: 12
Pages: 729-745
ISSN: 1759-4774 (ISSN-L)
1759-4782
DOI: 10.1038/s41571-019-0238-9
PMC: PMC13492067
OpenAlex: W2954542121
Cited by: 244
References: 216
Citations by year: 2026: 14 · 2025: 26 · 2024: 25 · 2023: 45 · 2022: 53 · 2021: 36 · 2020: 40 · 2019: 5
FWCI: 3.19
Type: journal article
Language: en
Open access: green
pmc.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (submittedVersion)
Funders: Massachusetts General Hospital
National Cancer Institute (R21CA241918, P01CA021239)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
Keywords: radiotherapy, antitumor immunity, immune checkpoint inhibitors, radiation-induced immunosuppression, immune response assessment, serum biomarkers, immune cell imaging, personalized radiotherapy, predictive biomarkers
MeSH terms: Combined Modality Therapy, Humans, Immune System, Immunotherapy, Neoplasms, Radiotherapy, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessing the interactions between radiotherapy and antitumour immunity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks